The contribution of positron emission tomography (PET) with 18F- fluorodeoxyglucose (FDG) in the preoperative detection of axillary metastases of breast cancer: The experience of the National Cancer Institute of Milan

Tumori

Volumn 83, Issue 2, 1997, Pages 542-543

  Crippa, Flavio ^a   Agresti, Roberto ^a   Delle Donne, Vincenzo ^a   Pascali, Claudio ^a   Bogni, Anna ^a   Chiesa, Carlo ^a   De Sanctis, Vinicio ^a   Schiavini, Mauro ^a   Decise, Donatella ^a   Bombardieri, Emilio ^a,b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Divisione di Medicina Nucleare   (Italy)

Author keywords

Axillary lymph node metastases; Breast cancer; FDG PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ITALY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION;

EID: 0030802043     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169708300211     Document Type: Conference Paper

References (10)

1. Danton D.N.: The role of axillary lymph node dissection in the management of breast cancer. Principles and practice of oncology, 6: 1-16, 1992.
2. NJH Consensus Conference. Treatment of early stage breast cancer. JAMA, 265: 391-395, 1991.
3. 18F]-fluoro-2-deoxy-D-glucose. Radiology, 179: 765-770, 1991.
4. Strauss L.G., Conti P.S.: The application of PET in clinical oncology. J. Nucl. Med., 32: 623-664, 1991.
5. Nielson Y.T., Hoh C.K., Hawkins R.A., Zinner M.J., Dahebom M., Choi Y., Maddahi J., Brunicardi F.C., Phelps M.E., Glapsy J.A.: The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease. Ann. Surg., 216 (1): 27-34, 1992.
6. 18F]-fluoro-2-deoxy-D-glucose. J. Comput. Assist. Tomogr., 17: 582-589, 1993.
7. Adler L.P., Crowe J.P., al Kaisi N.K., Sunshine J.L.: Evaluation of breast masses and axillary lymph nodes with (F-18)-2-deoxy-2-fluoro-D-glucose PET. Radiology, 187: 743-750, 1993.
8. Pietrzyk U., Scheidhauer K., Scharl A., Schicha H.: Presurgical visualization of primary breast carcinoma with PET emission and transmission imaging. J. Nucl. Med., 36: 1882-1884, 1995.
9. 18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicability. Eur. J. Nucl. Med., 23: 618-623, 1996.
10. 18F-FDG be cosidered as the best method? Int. J. Oncology, 8: 693-699, 1996.